サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1411885

腸疾患検査市場：検査対象病原体、技術、最終用途別-2024～2030年の世界予測

Enteric Disease Testing Market by Pathogen Tested (Campylobacter, Clostridium, E. coli), Technology (Chromatography & Spectrometry, Immunoassay, Polymerase Chain Reaction), End-Use - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 185 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
腸疾患検査市場：検査対象病原体、技術、最終用途別-2024～2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 185 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腸疾患検査市場規模は2023年に22億8,000万米ドルと推定され、2024年には24億1,000万米ドルに達し、CAGR 6.44%で2030年には35億3,000万米ドルに達すると予測されます。

腸疾患検査の世界市場

主要市場の統計
基準年[2023年] 22億8,000万米ドル
予測年[2024年] 24億1,000万米ドル
予測年[2030年] 35億3,000万米ドル
CAGR（%） 6.44%
腸疾患検査 Market-IMG1

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは腸疾患検査市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、腸疾患検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-腸疾患検査市場の市場規模と予測は？

2-腸疾患検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-腸疾患検査市場における技術動向と規制の枠組みは？

4-腸疾患検査市場における主要ベンダーの市場シェアは？

5-腸疾患検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • インスタント食品やインスタント食品の需要の増加
      • 腸疾患の罹患率の増加
      • 早期診断の利点についての個人間の意識の高まり
    • 抑制要因
      • 新興経済諸国における食品と水の検査にかかる高額な費用
    • 機会
      • 腸疾患検査における技術革新の出現
      • 有利な政府規制と償還政策
    • 課題
      • 新興経済諸国における病原体検査を管理する適切な規制の欠如
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 腸疾患検査市場病原体検査済み

  • イントロダクション
  • カンピロバクター
  • クロストリジウム
  • 大腸菌
  • 腸内細菌科
  • A型肝炎、B型肝炎、E型肝炎
  • リステリア菌
  • ノロウイルス
  • ロタウイルス
  • サルモネラ
  • 赤ブドウ球菌
  • ビブリオ

第7章 腸疾患検査市場：技術別

  • イントロダクション
  • クロマトグラフィーと分光分析
  • 免疫測定法
  • ポリメラーゼ連鎖反応
  • 迅速検査法
  • 従来的検査法

第8章 腸疾患検査市場：最終用途別

  • イントロダクション
  • 食品
    • 穀類と穀物
    • 乳製品
    • 果物と野菜
    • ハーブとスパイス
    • 肉、鶏肉、魚介類
    • ナッツ
    • 加工食品
  • 水

第9章 南北アメリカの腸疾患検査市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋の腸疾患検査市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの腸疾患検査市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第13章 競合ポートフォリオ

  • 主要な企業プロファイル
    • 3M Company
    • Alere, Inc.
    • Als Limited
    • Asure Quality
    • Becton, Dickinson and Company
    • BIO-RAD Laboratories, Inc.
    • Bureau Veritas Group
    • Eurofins Scientific
    • Hardy Diagnostics
    • Intertek Group plc
    • Merck KGAA
    • Merieux NutriSciences Corporation
    • Neogen Corporation
    • Nova Biologicals
    • Perkinelmer, Inc.
    • Romer Labs Division Holding GmbH
    • SGS SA
    • Symbio Laboratories
    • Thermo Fisher Scientific Inc.
    • TUV SUD
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. ENTERIC DISEASE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. ENTERIC DISEASE TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ENTERIC DISEASE TESTING MARKET DYNAMICS
  • FIGURE 7. ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2023 VS 2030 (%)
  • FIGURE 8. ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 12. ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. ENTERIC DISEASE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. ENTERIC DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ENTERIC DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 6. ENTERIC DISEASE TESTING MARKET SIZE, BY CAMPYLOBACTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ENTERIC DISEASE TESTING MARKET SIZE, BY CLOSTRIDIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ENTERIC DISEASE TESTING MARKET SIZE, BY E. COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ENTERIC DISEASE TESTING MARKET SIZE, BY ENTEROBACTERIACEAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ENTERIC DISEASE TESTING MARKET SIZE, BY HEPATITIS A, B, & E, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. ENTERIC DISEASE TESTING MARKET SIZE, BY LISTERIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ENTERIC DISEASE TESTING MARKET SIZE, BY NOROVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ENTERIC DISEASE TESTING MARKET SIZE, BY ROTAVIRUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ENTERIC DISEASE TESTING MARKET SIZE, BY SALMONELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ENTERIC DISEASE TESTING MARKET SIZE, BY SHIGELLA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ENTERIC DISEASE TESTING MARKET SIZE, BY VIBRIO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 18. ENTERIC DISEASE TESTING MARKET SIZE, BY CHROMATOGRAPHY & SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. ENTERIC DISEASE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ENTERIC DISEASE TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. ENTERIC DISEASE TESTING MARKET SIZE, BY RAPID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. ENTERIC DISEASE TESTING MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 26. ENTERIC DISEASE TESTING MARKET SIZE, BY CEREALS & GRAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. ENTERIC DISEASE TESTING MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. ENTERIC DISEASE TESTING MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. ENTERIC DISEASE TESTING MARKET SIZE, BY HERBS & SPICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. ENTERIC DISEASE TESTING MARKET SIZE, BY MEAT, POULTRY, & SEAFOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. ENTERIC DISEASE TESTING MARKET SIZE, BY NUTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. ENTERIC DISEASE TESTING MARKET SIZE, BY PROCESSED FOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. ENTERIC DISEASE TESTING MARKET SIZE, BY WATER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ENTERIC DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 81. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 85. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 86. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 89. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 90. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 93. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 94. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. SINGAPORE ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 97. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 98. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. SOUTH KOREA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 101. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 102. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. TAIWAN ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 105. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 106. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. THAILAND ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 109. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 110. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. VIETNAM ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 118. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 119. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. DENMARK ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 122. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 123. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. EGYPT ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 126. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 127. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. FINLAND ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 130. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 131. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 132. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. FRANCE ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 134. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 135. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. GERMANY ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 138. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 139. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. ISRAEL ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 142. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 143. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. ITALY ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 146. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 147. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. NETHERLANDS ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 150. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 151. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. NIGERIA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 154. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 155. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. NORWAY ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 158. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 159. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 160. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. POLAND ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 162. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 163. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. QATAR ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 166. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 167. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. RUSSIA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 170. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 171. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SAUDI ARABIA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 174. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 175. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SOUTH AFRICA ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 178. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 179. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. SPAIN ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 182. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 183. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. SWEDEN ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 186. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 187. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. SWITZERLAND ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 190. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 191. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. TURKEY ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. UNITED ARAB EMIRATES ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 198. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY PATHOGEN TESTED, 2018-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 200. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM ENTERIC DISEASE TESTING MARKET SIZE, BY FOOD, 2018-2030 (USD MILLION)
  • TABLE 202. ENTERIC DISEASE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 203. ENTERIC DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 204. ENTERIC DISEASE TESTING MARKET LICENSE & PRICING
目次
Product Code: MRR-732E7CFCB4C2

[185 Pages Report] The Enteric Disease Testing Market size was estimated at USD 2.28 billion in 2023 and expected to reach USD 2.41 billion in 2024, at a CAGR 6.44% to reach USD 3.53 billion by 2030.

Global Enteric Disease Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.28 billion
Estimated Year [2024] USD 2.41 billion
Forecast Year [2030] USD 3.53 billion
CAGR (%) 6.44%
Enteric Disease Testing Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Enteric Disease Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Enteric Disease Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Enteric Disease Testing Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Alere, Inc., Als Limited, Asure Quality, Becton, Dickinson and Company, BIO-RAD Laboratories, Inc., Bureau Veritas Group, Eurofins Scientific, Hardy Diagnostics, Intertek Group plc, Merck KGAA, Merieux NutriSciences Corporation, Neogen Corporation, Nova Biologicals, Perkinelmer, Inc., Romer Labs Division Holding GmbH, SGS SA, Symbio Laboratories, Thermo Fisher Scientific Inc., and TUV SUD.

Market Segmentation & Coverage

This research report categorizes the Enteric Disease Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Pathogen Tested
    • Campylobacter
    • Clostridium
    • E. coli
    • Enterobacteriaceae
    • Hepatitis A, B, & E
    • Listeria
    • Norovirus
    • Rotavirus
    • Salmonella
    • Shigella
    • Vibrio
  • Technology
    • Chromatography & Spectrometry
    • Immunoassay
    • Polymerase Chain Reaction
    • Rapid
    • Traditional
  • End-Use
    • Food
      • Cereals & Grain
      • Dairy products
      • Fruits & Vegetables
      • Herbs & Spices
      • Meat, Poultry, & Seafood
      • Nuts
      • Processed Food
    • Water
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Enteric Disease Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Enteric Disease Testing Market?

3. What are the technology trends and regulatory frameworks in the Enteric Disease Testing Market?

4. What is the market share of the leading vendors in the Enteric Disease Testing Market?

5. Which modes and strategic moves are suitable for entering the Enteric Disease Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Enteric Disease Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in demand for convenience foods and ready to go foods
      • 5.1.1.2. Increase prevalence of enteric diseases
      • 5.1.1.3. Surging awareness among individuals about the benefits of early diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. High cost regarding testing of food and water in developing economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of technological innovations in the enteric disease testing
      • 5.1.3.2. Favorable government regulations and reimbursement policies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of proper regulations governing pathogen testing in the developing economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Enteric Disease Testing Market, by Pathogen Tested

  • 6.1. Introduction
  • 6.2. Campylobacter
  • 6.3. Clostridium
  • 6.4. E. coli
  • 6.5. Enterobacteriaceae
  • 6.6. Hepatitis A, B, & E
  • 6.7. Listeria
  • 6.8. Norovirus
  • 6.9. Rotavirus
  • 6.10. Salmonella
  • 6.11. Shigella
  • 6.12. Vibrio

7. Enteric Disease Testing Market, by Technology

  • 7.1. Introduction
  • 7.2. Chromatography & Spectrometry
  • 7.3. Immunoassay
  • 7.4. Polymerase Chain Reaction
  • 7.5. Rapid
  • 7.6. Traditional

8. Enteric Disease Testing Market, by End-Use

  • 8.1. Introduction
  • 8.2. Food
    • 8.3.1. Cereals & Grain
    • 8.3.2. Dairy products
    • 8.3.3. Fruits & Vegetables
    • 8.3.4. Herbs & Spices
    • 8.3.5. Meat, Poultry, & Seafood
    • 8.3.6. Nuts
    • 8.3.7. Processed Food
  • 8.3. Water

9. Americas Enteric Disease Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Enteric Disease Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Enteric Disease Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. 3M Company
    • 13.1.2. Alere, Inc.
    • 13.1.3. Als Limited
    • 13.1.4. Asure Quality
    • 13.1.5. Becton, Dickinson and Company
    • 13.1.6. BIO-RAD Laboratories, Inc.
    • 13.1.7. Bureau Veritas Group
    • 13.1.8. Eurofins Scientific
    • 13.1.9. Hardy Diagnostics
    • 13.1.10. Intertek Group plc
    • 13.1.11. Merck KGAA
    • 13.1.12. Merieux NutriSciences Corporation
    • 13.1.13. Neogen Corporation
    • 13.1.14. Nova Biologicals
    • 13.1.15. Perkinelmer, Inc.
    • 13.1.16. Romer Labs Division Holding GmbH
    • 13.1.17. SGS SA
    • 13.1.18. Symbio Laboratories
    • 13.1.19. Thermo Fisher Scientific Inc.
    • 13.1.20. TUV SUD
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing